RNS Number : 1322X
GlaxoSmithKline PLC
17 December 2019
GlaxoSmithKline plc
Blocklisting Application
Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 370,000 Ordinary Shares of 25p each ('Shares') to be admitted to the Official List.
The Shares are being reserved under an existing blocklisting and will be issued under the GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan.
When issued, the Shares will rank pari passu with the existing Ordinary Shares of 25p each.
Admission is expected to be effective on 18 December 2019.
Victoria Whyte
Company Secretary
17 December 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
